These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22393212)
1. Breast cancer in men. Gethins M J Natl Cancer Inst; 2012 Mar; 104(6):436-8. PubMed ID: 22393212 [No Abstract] [Full Text] [Related]
2. Male breast cancer. Joseph A; Mokbel K Int J Fertil Womens Med; 2004; 49(5):198-9. PubMed ID: 15633473 [TBL] [Abstract][Full Text] [Related]
3. Cancer: crossing over to drug resistance. Livingston DM; Silver DP Nature; 2008 Feb; 451(7182):1066-7. PubMed ID: 18305536 [No Abstract] [Full Text] [Related]
4. BRCA in breast cancer: from risk assessment to therapeutic prediction. Diamond JR; Borges VF; Eckhardt SG; Jimeno A Drug News Perspect; 2009 Dec; 22(10):603-8. PubMed ID: 20140280 [TBL] [Abstract][Full Text] [Related]
5. [Inherited breast and ovarian cancers]. Gerdes AM; Ejlertsen B Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422 [TBL] [Abstract][Full Text] [Related]
6. Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer. Domchek SM; Mitchell G; Lindeman GJ; Tung NM; BalmaƱa J; Isakoff SJ; Schmutzler R; Audeh MW; Loman N; Scott C; Friedlander M; Kaufman B; Garber JE; Tutt A; Robson ME J Clin Oncol; 2011 Nov; 29(32):4224-6. PubMed ID: 21931031 [No Abstract] [Full Text] [Related]
7. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data. Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer in men. Mudlin AK Radiol Technol; 2002; 74(2):159-61. PubMed ID: 12462964 [No Abstract] [Full Text] [Related]
9. PARP inhibitors: will the new class of drugs match the hype? Tuma RS J Natl Cancer Inst; 2009 Sep; 101(18):1230-2. PubMed ID: 19738163 [No Abstract] [Full Text] [Related]
10. Male breast cancer. Ottini L; Palli D; Rizzo S; Federico M; Bazan V; Russo A Crit Rev Oncol Hematol; 2010 Feb; 73(2):141-55. PubMed ID: 19427229 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2. Drew Y; Mulligan EA; Vong WT; Thomas HD; Kahn S; Kyle S; Mukhopadhyay A; Los G; Hostomsky Z; Plummer ER; Edmondson RJ; Curtin NJ J Natl Cancer Inst; 2011 Feb; 103(4):334-46. PubMed ID: 21183737 [TBL] [Abstract][Full Text] [Related]
13. Screening mammography in men with BRCA mutations: is there a role? Freedman BC; Keto J; Rosenbaum Smith SM Breast J; 2012; 18(1):73-5. PubMed ID: 22226069 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of male breast cancer. Weiss JR; Moysich KB; Swede H Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):20-6. PubMed ID: 15668471 [TBL] [Abstract][Full Text] [Related]
15. PARP inhibition: targeting the Achilles' heel of DNA repair to treat germline and sporadic ovarian cancers. Carden CP; Yap TA; Kaye SB Curr Opin Oncol; 2010 Sep; 22(5):473-80. PubMed ID: 20485165 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatment of male breast cancer. Hayes TG Expert Opin Pharmacother; 2009 Oct; 10(15):2499-510. PubMed ID: 19708850 [TBL] [Abstract][Full Text] [Related]
17. Male breast cancer--an andrological disease: risk factors and diagnosis. Krause W Andrologia; 2004 Dec; 36(6):346-54. PubMed ID: 15541050 [TBL] [Abstract][Full Text] [Related]
18. Summaries for patients. Breast cancer in men. Ann Intern Med; 2002 Oct; 137(8):I63. PubMed ID: 12379091 [No Abstract] [Full Text] [Related]
19. 19. Male breast cancer: aetiology, genetics and clinical management. Tischkowitz MD; Hodgson SV; Fentiman IS Int J Clin Pract; 2002 Dec; 56(10):750-4. PubMed ID: 12510948 [TBL] [Abstract][Full Text] [Related]